Molecular genetics of congenital heart disease DOI
Xiaoqing Zhang, Ming Qi, Qihua Fu

et al.

Science China Life Sciences, Journal Year: 2025, Volume and Issue: unknown

Published: March 27, 2025

Language: Английский

Multi-chamber cardioids unravel human heart development and cardiac defects DOI Creative Commons

Clara Schmidt,

Alison Deyett, Tobias Ilmer

et al.

Cell, Journal Year: 2023, Volume and Issue: 186(25), P. 5587 - 5605.e27

Published: Nov. 28, 2023

The number one cause of human fetal death are defects in heart development. Because the embryonic is inaccessible and impacts mutations, drugs, environmental factors on specialized functions different compartments not captured by vitro models, determining underlying causes difficult. Here, we established a cardioid platform that recapitulates development all major compartments, including right left ventricles, atria, outflow tract, atrioventricular canal. By leveraging 2D 3D differentiation, efficiently generated progenitor subsets with distinct first, anterior, posterior second field identities. This advance enabled reproducible generation cardioids compartment-specific vivo-like gene expression profiles, morphologies, functions. We used this to unravel ontogeny signal contraction propagation between interacting chambers dissect how teratogens, drugs developing heart.

Language: Английский

Citations

78

Modeling the atrioventricular conduction axis using human pluripotent stem cell-derived cardiac assembloids DOI Creative Commons
Jiuru Li, Alexandra Wiesinger,

Lianne Fokkert

et al.

Cell stem cell, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 1, 2024

Language: Английский

Citations

8

Advances in 3D Bioprinted Cardiac Tissue Using Stem Cell-Derived Cardiomyocytes DOI Creative Commons
Jacqueline M. Bliley, Maria Stang, Anne Behre

et al.

Stem Cells Translational Medicine, Journal Year: 2024, Volume and Issue: 13(5), P. 425 - 435

Published: March 19, 2024

Abstract The ultimate goal of cardiac tissue engineering is to generate new muscle repair or replace the damaged heart. This requires advances in stem cell technologies differentiate billions cardiomyocytes, together with advanced biofabrication approaches such as 3D bioprinting achieve requisite structure and contractile function. In this concise review, we cover recent progress using pluripotent cell-derived key design criteria for aligned tissues, ongoing challenges field that must be addressed realize goal.

Language: Английский

Citations

7

Clinical trials in-a-dish for cardiovascular medicine DOI
Xuekun Wu, Kyle Swanson, Zehra Yıldırım

et al.

European Heart Journal, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 13, 2024

Abstract Cardiovascular diseases persist as a global health challenge that requires methodological innovation for effective drug development. Conventional pipelines relying on animal models suffer from high failure rates due to significant interspecies variation between humans and models. In response, the recently enacted Food Drug Administration Modernization Act 2.0 encourages alternative approaches including induced pluripotent stem cells (iPSCs). Human iPSCs provide patient-specific, precise, screenable platform testing, paving way cardiovascular precision medicine. This review discusses milestones in iPSC differentiation their applications disease modelling discovery It then explores challenges emerging opportunities implementation of ‘clinical trials in-a-dish’. Concluding, this proposes framework future clinical trial design with strategic incorporations technology, microphysiological systems, pan-omics, artificial intelligence improve success advance healthcare.

Language: Английский

Citations

7

Advances in the Generation of Constructed Cardiac Tissue Derived from Induced Pluripotent Stem Cells for Disease Modeling and Therapeutic Discovery DOI Creative Commons
Truman J. Roland, Kunhua Song

Cells, Journal Year: 2024, Volume and Issue: 13(3), P. 250 - 250

Published: Jan. 29, 2024

The human heart lacks significant regenerative capacity; thus, the solution to failure (HF) remains organ donation, requiring surgery and immunosuppression. demand for constructed cardiac tissues (CCTs) model treat disease continues grow. Recent advances in induced pluripotent stem cell (iPSC) manipulation, CRISPR gene editing, 3D tissue culture have enabled a boom iPSC-derived CCTs (iPSC-CCTs) with diverse types architecture. Compared 2D-cultured cells, iPSC-CCTs better recapitulate biology, demonstrating potential advance modeling, drug discovery, medicine, though could benefit from methods faithfully mimic physiology electrophysiology. Here, we summarize future developments vascularization, immunization, maturation of study therapy.

Language: Английский

Citations

6

Progress of organoid platform in cardiovascular research DOI Creative Commons

Xingchao Du,

Hao Jia,

Yuan Chang

et al.

Bioactive Materials, Journal Year: 2024, Volume and Issue: 40, P. 88 - 103

Published: June 9, 2024

Language: Английский

Citations

6

HAND factors regulate cardiac lineage commitment and differentiation from human pluripotent stem cells DOI Creative Commons

Huixin Guo,

Chengwen Hang,

Bowen Lin

et al.

Stem Cell Research & Therapy, Journal Year: 2024, Volume and Issue: 15(1)

Published: Feb. 5, 2024

Transcription factors HAND1 and HAND2 (HAND1/2) play significant roles in cardiac organogenesis. Abnormal expression deficiency of HAND1/2 result severe defects. However, the function mechanism regulating human early lineage commitment differentiation are still unclear. With NKX2.5eGFP H9 embryonic stem cells (hESCs), we established single double knockout cell lines for HAND2, respectively, whose cardiomyocyte efficiency could be monitored by assessing NKX2.5-eGFP+ with flow cytometry. The specific markers heart fields subtypes was examined quantitative PCR, western blot immunofluorescence staining. Microelectrode array whole-cell patch clamp were performed to determine electrophysiological characteristics differentiated cardiomyocytes. transcriptomic changes HAND revealed RNA sequencing. target genes identified validated experimentally integrating chromatin immunoprecipitation sequencing data. Either or did not affect kinetics, whereas depletion resulted delayed onset. biased mesoderm toward second field progenitors at expense first progenitors, leading increased atrial outflow tract markers, which further confirmed appearance atrial-like action potentials. By contrast, cardiomyocytes had reduced displayed ventricular-like HAND1/2-deficient hESCs more inclined its derived potentials than during differentiation. Further mechanistic investigations suggested TBX5 as one downstream targets HAND1/2, overexpression partially restored abnormal hESCs. have redundant These findings only reveal essential organogenesis, but also provide important information on pathogenesis deficiency-related congenital diseases, potentially lead new therapeutic strategies.

Language: Английский

Citations

5

Canonical Wnt signaling directs the generation of functional human PSC-derived atrioventricular canal cardiomyocytes in bioprinted cardiac tissues DOI Creative Commons

Chenxi Ye,

Chuanlai Yang,

Heqiang Zhang

et al.

Cell stem cell, Journal Year: 2024, Volume and Issue: 31(3), P. 398 - 409.e5

Published: Feb. 15, 2024

The creation of a functional 3D bioprinted human heart remains challenging, largely due to the lack some crucial cardiac cell types, including atrioventricular canal (AVC) cardiomyocytes, which are essential slow down electrical impulse between atrium and ventricle. By utilizing single-cell RNA sequencing analysis bioprinting technology, we discover that stage-specific activation canonical Wnt signaling creates AVC cardiomyocytes derived from pluripotent stem cells. These display morphological characteristics express molecular markers transcription factors TBX2 MSX2. When in prefabricated tissues, these successfully delay impulse, demonstrating their capability functioning as vitro. Thus, findings not only identify key regulator cardiomyocyte differentiation vitro, but, more importantly, provide critical cellular source for biofabrication heart.

Language: Английский

Citations

5

Circadian rhythms in cardiovascular (dys)function: approaches for future therapeutics DOI Creative Commons
Margaux Lecacheur,

Daniëlle J. M. Ammerlaan,

Pieterjan Dierickx

et al.

Deleted Journal, Journal Year: 2024, Volume and Issue: 1(1)

Published: Sept. 23, 2024

Abstract The circadian clock is an evolutionarily conserved time-keeper that regulates physiological processes across 24 h. In the cardiovascular system, several parameters, such as blood pressure, heart rate, and metabolism, exhibit time-of-day variations. These features are in part driven by clock. Chronic perturbation of diurnal rhythmicity due to shift work or irregular social schedules has been associated with increased risk hypertension, arrhythmias, myocardial infarction. This review discusses impact rhythms on human health effect disruption occurrence adverse cardiac events. Additionally, we discuss how main factors diseases, obesity, sleep disorders, aging, affect rhythms. Finally, elaborate chronotherapy well targeting highlight novel approaches translate our scientific understanding into clinical practice.

Language: Английский

Citations

5

Micro‐Engineered Heart Tissues On‐Chip with Heterotypic Cell Composition Display Self‐Organization and Improved Cardiac Function DOI Creative Commons
Carla Cofiño‐Fabrés, Tom Boonen, José M. Rivera‐Arbeláez

et al.

Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: 13(18)

Published: March 12, 2024

Advanced in vitro models that recapitulate the structural organization and function of human heart are highly needed for accurate disease modeling, more predictable drug screening, safety pharmacology. Conventional 3D Engineered Heart Tissues (EHTs) lack heterotypic cell complexity culture under flow, whereas microfluidic Heart-on-Chip (HoC) general configuration contractile readouts. In this study, an innovative user-friendly HoC model is developed to overcome these limitations, by culturing pluripotent stem (hPSC)-derived cardiomyocytes (CMs), endothelial (ECs)- smooth muscle cells (SMCs), together with cardiac fibroblasts (FBs), underflow, leading self-organized miniaturized micro-EHTs (µEHTs) a CM-EC interface reminiscent physiological capillary lining. µEHTs cultured flow display enhanced performance conduction velocity. addition, presence EC layer altered responses µEHT contraction. This observation suggests potential barrier-like ECs, which may affect availability drugs CMs. These increased complexity, will pave way screen therapeutic targets predict efficacy.

Language: Английский

Citations

4